SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-19-017828
Filing Date
2019-09-12
Accepted
2019-09-12 08:14:01
Documents
4
Effectiveness Date
2019-09-12

Document Format Files

Seq Description Document Type Size
1 f8k091219_amagpharma.htm DEFA14A 16612
2 PRESS RELEASE ISSUED BY AMAG PHARMACEUTICALS, INC. ON SEPTEMBER 12, 2019 f8k091219ex99-1_amag.htm EX-99.1 19514
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9810
4 GRAPHIC image_001.jpg GRAPHIC 14468
  Complete submission text file 0001213900-19-017828.txt   71019
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-10865 | Film No.: 191089548
SIC: 2834 Pharmaceutical Preparations